<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Despite the high rate of occurrence of both <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> in humans, the cardiovascular effects of the two conditions have not been investigated when they occur simultaneously </plain></SENT>
<SENT sid="1" pm="."><plain>Thus this study examined the vascular effects of simultaneous type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and renal <z:hpo ids='HP_0000822'>hypertension</z:hpo> on endothelial function </plain></SENT>
<SENT sid="2" pm="."><plain>Serum malondialdehyde and systolic blood pressure (SBP) were measured, <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GTT</z:e>) was performed, and concentration-response to <z:chebi fb="0" ids="8093">phenylephrine</z:chebi> (PE) in the absence and presence of <z:chebi fb="13" ids="29785">nitro</z:chebi>-l-arginine <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> (l-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e>), <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> and <z:chebi fb="0" ids="29321">sodium nitroprusside</z:chebi> were conducted on aortic rings from diabetic control, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, sham-operated, renal hypertensive, and simultaneous type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> plus <z:hpo ids='HP_0000822'>hypertension</z:hpo> rats respectively </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000822'>Hypertension</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp>, and simultaneous <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> were associated with either increased or decreased maximal responses (E(max)) of PE dependent on in the presence or absence of l-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>There was also increased serum malondialdehyde and decreased E(max) of <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Thus simultaneous <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:mp ids='MP_0002055'>diabetes</z:mp> caused a greater decrease in E(max) of <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> compared to that seen with either <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:hpo ids='HP_0000822'>hypertension</z:hpo> alone higher than that seen in <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The blood <z:chebi fb="105" ids="17234">glucose</z:chebi> during <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GTT</z:e> was lower than that seen in <z:mp ids='MP_0002055'>diabetes</z:mp> groups </plain></SENT>
<SENT sid="7" pm="."><plain>Thus simultaneous type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and the SBP was renal <z:hpo ids='HP_0000822'>hypertension</z:hpo> is associated with <z:mp ids='MP_0005292'>improved glucose tolerance</z:mp>, but with further deterioration of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> compared with either condition alone </plain></SENT>
</text></document>